Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
11/28/2000 | US6153613 2,3-diketopiperazine derivatives or their salts |
11/28/2000 | US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders |
11/28/2000 | CA2173788C Substituted thiophene derivative and agricultural and horticultural fungicide containing the same as active ingredient |
11/23/2000 | WO2000069849A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
11/23/2000 | WO2000069842A1 Benzofuranylsulfonates |
11/23/2000 | WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
11/23/2000 | WO2000069833A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
11/23/2000 | WO2000069832A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
11/23/2000 | WO2000069826A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
11/23/2000 | WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
11/23/2000 | WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
11/23/2000 | WO2000069810A1 Glucagon antagonists/inverse agonists |
11/23/2000 | WO1999065871A3 Thiolesters and uses thereof |
11/23/2000 | CA2373892A1 Glucagon antagonists/inverse agonists |
11/23/2000 | CA2373666A1 Benzofuranylsulfonates |
11/23/2000 | CA2373614A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
11/23/2000 | CA2373610A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
11/23/2000 | CA2373510A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
11/23/2000 | CA2373509A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
11/23/2000 | CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
11/23/2000 | CA2372617A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
11/23/2000 | CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
11/22/2000 | EP1054004A1 Novel pyrimidine-5-carboxamide derivatives |
11/22/2000 | EP1054003A1 Urocanic acid derivatives |
11/22/2000 | EP1053227A1 Ppar-gamma modulators |
11/22/2000 | EP1053226A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
11/22/2000 | CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors |
11/22/2000 | CN1058709C Amide compounds for medical treatment |
11/21/2000 | US6150530 Amidation of amine with acid |
11/21/2000 | US6150526 Piperidine derivative having renin inhibiting activity |
11/21/2000 | US6150394 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
11/21/2000 | US6150386 Pest control, in particular, as microbicides, insecticides and acaricides in agriculture, in horticulture and hygiene sector; crop storage; fungicides |
11/21/2000 | US6150385 Viricide with activity against cytomegalo virus (cmv), herpes virus including varicella zoster virus, the epstein-barr virus, the herpes simplex virus, and the human herpes virus type 8 (hhv-8) |
11/21/2000 | US6150379 Compounds and compositions as anticoagulants |
11/21/2000 | US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone |
11/21/2000 | US6150371 Method for preventing and for treating autoimmune disease |
11/21/2000 | US6150366 Crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles with specific particle size are useful as antipsychosis agent |
11/21/2000 | US6150362 Administering 1,3,5-substituted triazine compounds to the patient suffering from angiogenic diseases |
11/21/2000 | US6150356 Potassium channel inhibitors and method |
11/21/2000 | US6150352 Antagonists of gonadotropin releasing hormone |
11/21/2000 | US6150334 Serine protease inhibitors-tripeptoid analogs |
11/16/2000 | WO2000068228A1 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents |
11/16/2000 | WO2000068224A1 Substituted benzolactam compounds |
11/16/2000 | WO2000068208A1 Pyrimidinones derivatives for the treatment of atherosclerosis |
11/16/2000 | WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
11/16/2000 | WO2000068201A1 Quinoline derivatives as inhibitors of mek enzymes |
11/16/2000 | WO2000068199A1 Quinoline derivatives as inhibitors of mek enzymes |
11/16/2000 | WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
11/16/2000 | WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
11/16/2000 | WO2000032180A3 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituted indolealkanoic acids |
11/16/2000 | WO2000028822A3 Herbicidal 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidine-2,4-diones |
11/16/2000 | WO2000020556A3 Zinc finger-reactive antimicrobial compounds |
11/16/2000 | WO2000020358A3 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
11/16/2000 | WO2000015634A3 Hiv protease inhibitors |
11/16/2000 | WO2000009103A3 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
11/16/2000 | DE19923001A1 New epothilone derivatives, used as mitosis regulators e.g. for treating malignant tumors, psoriasis or arthritis |
11/16/2000 | CA2373293A1 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents |
11/16/2000 | CA2373079A1 Substituted benzolactam compounds |
11/16/2000 | CA2372663A1 Quinoline derivatives as inhibitors of mek enzymes |
11/16/2000 | CA2371469A1 Quinoline derivatives as inhibitors of mek enzymes |
11/16/2000 | CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
11/15/2000 | EP1052261A1 Pyran derivatives and use thereof |
11/15/2000 | EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics. |
11/15/2000 | EP1051415A1 Benzamide derivatives as vasopressin antagonists |
11/15/2000 | EP1051414A1 Substituted heteroarylmethyl compounds used as herbicides |
11/15/2000 | EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
11/15/2000 | EP1051170A1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration |
11/15/2000 | EP1051169A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
11/15/2000 | CN1273585A Substituted 3-(1,2-benzisothiazol or isoxazel-5-yl)-substituted pyrimidine as heribicides |
11/15/2000 | CN1058492C Benzothiazine derivative |
11/15/2000 | CN1058490C Tetrazolinone derivatives |
11/14/2000 | US6147101 Treating hyperglycemia |
11/14/2000 | US6147100 Antiinflammatory agents |
11/14/2000 | US6147099 Oxazolidinedione derivatives, their production and use |
11/14/2000 | US6147090 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular |
11/14/2000 | US6147087 Use of 1,2-Bridged 1,4-dihydropyridines as medicaments |
11/14/2000 | US6147083 Novel substituted 1,2-ethanediamine derivatives which antagonize the pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins, useful for the treatment of asthma, etc. |
11/14/2000 | CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives |
11/09/2000 | WO2000066618A1 Integrin receptor antagonists |
11/09/2000 | WO2000066589A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
11/09/2000 | WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
11/09/2000 | WO2000066571A1 Cyclocarbamate derivatives as progesterone receptor modulators |
11/09/2000 | WO2000066568A1 Pesticidal triazine derivatives |
11/09/2000 | WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
11/09/2000 | WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists |
11/09/2000 | WO2000066119A1 Novel prolines as antimicrobial agents |
11/09/2000 | WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
11/09/2000 | WO2000066102A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
11/09/2000 | WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
11/09/2000 | WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
11/09/2000 | WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
11/09/2000 | WO2000035437A3 Improving mental performance by increasing brain insulin sensitivity |
11/09/2000 | DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application |
11/09/2000 | CA2372176A1 Novel prolines as antimicrobial agents |
11/09/2000 | CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
11/09/2000 | CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators |
11/09/2000 | CA2371604A1 Integrin receptor antagonists |
11/09/2000 | CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
11/08/2000 | EP1049744A1 Asymmetric cyanine dye quenchers |
11/08/2000 | EP1049694A1 Benzothiadiazoles and derivatives |